Lizzul Paul F.
Chief Medical Officer
Lizzul Paul F. has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jan 9, 2026.
On the most recent filing, Lizzul Paul F. is listed as Chief Medical Officer at ANAPTYSBIO, INC. Inside the rolling window, Lizzul Paul F. reported no open-market purchases and 4 open-market sales totaling $522K in ANAB. The largest disclosed transaction in the window is a sale of 4,219 ANAB shares on Jan 5, 2026, worth $183K.
Companies traded
Other insiders at ANAB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$522K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lizzul Paul F. made?
Lizzul Paul F. has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Lizzul Paul F. trade?
Lizzul Paul F. has filed SEC Form 4 disclosures for 1 company, including ANAB.
When was Lizzul Paul F.'s most recent SEC Form 4 filing?
Lizzul Paul F.'s most recent SEC Form 4 filing on Tracefour is dated Jan 9, 2026.
What is Lizzul Paul F.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Lizzul Paul F. is listed as Chief Medical Officer.
What is Lizzul Paul F.'s total buy and sell value in the current window?
Inside the rolling retention window, Lizzul Paul F. bought $0 and sold $522K based on SEC Form 4 filings.
What was Lizzul Paul F.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,219 ANAB shares on 2026-01-05, worth $183K, per SEC Form 4 filings.